跳至主要内容
临床试验/NCT03929731
NCT03929731已完成不适用

To Determine Long-term Outcomes, Recurrence Rates, and Treatment Needs in Polypoidal Choroidal Vasculopathy(PCV)

Singapore National Eye Centre3 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2019年7月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
72
试验地点
3
主要终点
Long term prognostication

研究概览

简要总结

To determine long-term outcomes, recurrence rates, and treatment needs in Polypoidal Choroidal Vasculopathy (PCV). Specifically, to describe the long-term outcomes, recurrence rates and treatment patterns PCV patients 5 years after first presentation. This study will also evaluate whether polyp closure within the first 12 months of therapy is associated with better long-term visual outcome and will also determine the risk of disease development in the fellow eye

详细描述

The investigators will conduct a non-interventional, observational cohort study to assess the visual outcome of patients who have completed one of three recent randomized controlled trials in Polypoidal Choroidal Vasculopathy (PCV) EVERESTII, PLANET, PCV Treat and Extend (T&E) study. After completion of the randomized controlled trails (2 years for EVEREST II and PLANET; 1 year for T&E study), patients will be released from clinical trial protocol. At approximately 6 years (2019-2024), patients will be contacted by research coordinators and invited to attend a follow-up examination.

Study Design:

Non-interventional, observational, cohort study

Clinical coordinators will contact patients of:

  • EVEREST II (2013-2015)
  • PLANET (2014-2015)
  • PCV T&E (2018-2019) at ~72 +/- 6 months after their initial baseline visits (2019-2024) Study Visits and Procedures Participants will only be expected to attend 1 evaluation clinic which will last approximately 3 hours

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Participants will have completed the previous PCV RCTs: EVEREST II, PLANET and PCV T&E studies
  • Are able to give consent for this follow up study

排除标准

  • No exclusion criteria unless they do not meet the inclusion criteria

结局指标

主要结局

Long term prognostication

时间窗: within 72 months

Long term recurrence rates, correlated baseline characteristics and initial treatment strategies correlated to long term outcomes

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Gemmy Cheung Chui Ming

Professor

Singapore National Eye Centre

研究点 (3)

Loading locations...

相似试验